Table 3.
Influence of age and gender on comorbidities
| Age | Gender | |||||||
|---|---|---|---|---|---|---|---|---|
| < 30 | 30–45 | 45–60 | 60–75 | > 75 | Male | Female | ||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
| Hypertensiona | no | 21 (7.8) | 55 (20.4) | 97 (35.9) | 65 (24.1) | 32 (11.9) | 155 (57.4) | 115 (42.6) |
| yes | 1 (0.3) | 9 (3.1) | 50 (17.1) | 116 (39.6) | 117 (39.9) | 182 (62.1) | 111 (37.9) | |
| Dyslipidaemiaa | no | 22 (5.6) | 59 (15.0) | 117 (29.7) | 108 (27.4) | 88 (22.3) | 227 (57.6) | 167 (42.4) |
| yes | 0 (0.0) | 3 (1.9) | 30 (18.9) | 68 (42.8) | 58 (36.5) | 103 (64.8) | 56 (35.2) | |
| Diabetesa | no | 21 (5.0) | 58 (13.7) | 128 (30.3) | 114 (27.0) | 101 (23.9) | 241 (57.1) | 181 (42.9) |
| yes | 1 (0.8) | 6 (4.6) | 19 (14.5) | 63 (48.1) | 42 (32.1) | 88 67.2) | 43 (32.8) |
aall Chi Squared p-values either vs age or gender were < 0.001